Larotinib

Larotinib is an orally active, potent, and broad-spectrum tyrosine kinase inhibitor (TKI) with an IC50 of 0.6 nM for EGFR.

1438072-11-7

≥ 2 years

>98% (HPLC)

488.94

C24H26ClFN4O4

Research use only, not for human use.

BTK | Tyrosine Kinases | IRAK | EGFR

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

TA801826BM 100 µL

Ask

abx538673 96 Tests

Ask

MF-0082197-01 50 µL

Ask

MF-0082197-02 100 µL

Ask

MF-0082197-03 200 µL

Ask

SI213072A 1 Each

Ask